These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 34430379)

  • 1. Local ablative therapies in oligometastatic NSCLC-upfront or outback?-a narrative review.
    Tjong MC; Louie AV; Iyengar P; Solomon BJ; Palma DA; Siva S
    Transl Lung Cancer Res; 2021 Jul; 10(7):3446-3456. PubMed ID: 34430379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local Consolidative Therapy for Oligometastatic Non-Small Cell Lung Cancer.
    Santos PMG; Li X; Gomez DR
    Cancers (Basel); 2022 Aug; 14(16):. PubMed ID: 36010969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oligoprogression in non-small cell lung cancer: a narrative review.
    Nguyen KT; Sakthivel G; Milano MT; Qiu H; Singh DP
    J Thorac Dis; 2022 Dec; 14(12):4998-5011. PubMed ID: 36647502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changing equipoise in the landscape of radiation for oligometastatic lung cancer.
    Schroeder SR; Leenders M; Iyengar P; de Ruysscher D
    Transl Lung Cancer Res; 2019 Sep; 8(Suppl 2):S184-S191. PubMed ID: 31673523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consolidative Local Ablative Therapy Improves the Survival of Patients With Synchronous Oligometastatic NSCLC Harboring EGFR Activating Mutation Treated With First-Line EGFR-TKIs.
    Xu Q; Zhou F; Liu H; Jiang T; Li X; Xu Y; Zhou C
    J Thorac Oncol; 2018 Sep; 13(9):1383-1392. PubMed ID: 29852232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereotactic ablative body radiation for oligometastatic and oligoprogressive disease.
    Ning MS; Gomez DR; Heymach JV; Swisher SG
    Transl Lung Cancer Res; 2019 Feb; 8(1):97-106. PubMed ID: 30788239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local ablative therapy in oncogenic-driven oligometastatic non-small cell lung cancer: present and ongoing strategies-a narrative review.
    Fallet V; Matton L; Schernberg A; Canellas A; Cornelis FH; Cadranel J
    Transl Lung Cancer Res; 2021 Jul; 10(7):3457-3472. PubMed ID: 34430380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiotherapy for Oligometastatic Non-Small Cell Lung Cancer: Past, Present, and Future.
    McCall N; Higgins K
    Oncology (Williston Park); 2021 Jun; 35(6):313-319. PubMed ID: 34139791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Consolidative stereotactic ablative radiotherapy (SABR) to intrapulmonary lesions is associated with prolonged progression-free survival and overall survival in oligometastatic NSCLC patients: A prospective phase 2 study.
    Blake-Cerda M; Lozano-Ruíz F; Maldonado-Magos F; de la Mata-Moya D; Díaz-García D; Lara-Mejía L; Zatarain-Barrón ZL; Cuevas-Góngora MF; Barron-Barron F; Corona-Cruz JF; Cabrera-Miranda L; Arroyo-Hernández M; Gerson R; Arrieta O
    Lung Cancer; 2021 Feb; 152():119-126. PubMed ID: 33385737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results of Radiation Therapy as Local Ablative Therapy for Oligometastatic Non-Small Cell Lung Cancer.
    Billing DL; Rimner A
    Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Radiosurgery and Stereotactic Ablative Radiotherapy for Oligometastatic Non-Oncogene Addicted NSCLC.
    Badellino S; Levis M; Cuffini EM; Cerrato M; Orlandi E; Chiovatero I; Aprile A; Gastino A; Cavallin C; Iorio GC; Parise R; Mantovani C; Ricardi U
    Cancers (Basel); 2022 Mar; 14(6):. PubMed ID: 35326616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oligometastatic non-small cell lung cancer: a narrative review of stereotactic ablative radiotherapy.
    Dohopolski M; Iyengar P
    Ann Palliat Med; 2021 May; 10(5):5944-5953. PubMed ID: 33691460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local therapy treatment conditions for oligometastatic non-small cell lung cancer.
    Zhang S; Sun Q; Cai F; Li H; Zhou Y
    Front Oncol; 2022; 12():1028132. PubMed ID: 36568167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Local Ablative Therapy in Patients with Oligometastatic and Oligoprogressive Non-Small Cell Lung Cancer.
    Kim C; Hoang CD; Kesarwala AH; Schrump DS; Guha U; Rajan A
    J Thorac Oncol; 2017 Feb; 12(2):179-193. PubMed ID: 27780780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oligometastatic breast cancer: where are we now and where are we headed?-a narrative review.
    Kent CL; McDuff SGR; Salama JK
    Ann Palliat Med; 2021 May; 10(5):5954-5968. PubMed ID: 32921069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local ablative radiotherapy for oligometastatic non-small cell lung cancer.
    Suh YG; Cho J
    Radiat Oncol J; 2019 Sep; 37(3):149-155. PubMed ID: 31591862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local Consolidation Therapy (LCT) After First Line Tyrosine Kinase Inhibitor (TKI) for Patients With EGFR Mutant Metastatic Non-small-cell Lung Cancer (NSCLC).
    Elamin YY; Gomez DR; Antonoff MB; Robichaux JP; Tran H; Shorter MK; Bohac JM; Negrao MV; Le X; Rinsurogkawong W; Lewis J; Lacerda L; Roarty EB; Swisher SG; Roth JA; Zhang J; Papadimitrakopoulou V; Heymach JV
    Clin Lung Cancer; 2019 Jan; 20(1):43-47. PubMed ID: 30343004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local Ablative Therapy Combined With Pembrolizumab in Patients With Synchronous Oligometastatic Non-Small Cell Lung Cancer: A Recursive Partitioning Analysis.
    Lee HI; Choi EK; Kim SS; Shin YS; Park J; Choi CM; Yoon S; Kim HR; Cho YH; Song SY
    Int J Radiat Oncol Biol Phys; 2024 Nov; 120(3):698-707. PubMed ID: 38797499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of Surgery for Oligometastatic Non-Small Cell Lung Cancer.
    Euhus CJ; Ripley TR; Medina CG
    Cancers (Basel); 2022 May; 14(10):. PubMed ID: 35626125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local Ablative Therapy in Oligometastatic NSCLC.
    Li X; Gomez D; Iyengar P
    Semin Radiat Oncol; 2021 Jul; 31(3):235-241. PubMed ID: 34090650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.